The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Emerald Advisers and Fm Investments launch innovative life sciences ETF on Nasdaq
Emerald Advisers and F/m Investments have launched the F/m Emerald Life Sciences Innovation ETF (LFSC) on the Nasdaq, targeting innovative small and mid-cap companies in the life sciences sector, including biotech and medical technology. The ETF utilizes a proprietary 10-Step Research Process to identify high-potential firms, aiming to capitalize on the rapid growth in healthcare driven by an aging population and increased demand for medical advancements. With U.S. healthcare spending projected to rise significantly, LFSC offers investors diversified exposure to transformative developments in the industry.